Gene · 8793
Papers1,762
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,762
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Core Fucosylation Mediated by the FucT-8 Enzyme Affects TRAIL-Induced Apoptosis and Sensitivity to Chemotherapy in Human SW480 and SW620 Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37569254 | PubTator, text mining | PubMed |
| Adipose tissue coregulates cognitive function. | Sci Adv | 2023 | 37566655 | PubTator, text mining | PubMed |
| Competition for cysteine acylation by C16:0 and C18:0 derived lipids is a global phenomenon in the proteome. | J Biol Chem | 2023 | 37495107 | PubTator, text mining | PubMed |
| The effect of matrices on the gene expression profile of patient-derived head and neck carcinoma cells for in vitro therapy testing. | Cancer Cell Int | 2023 | 37488620 | PubTator, text mining | PubMed |
| Nicotinamide mononucleotide (NMN) alleviates the poly(I:C)-induced inflammatory response in human primary cell cultures. | Sci Rep | 2023 | 37474783 | PubTator, text mining | PubMed |
| Anticancer properties of red beetroot hydro-alcoholic extract and its main constituent; betanin on colorectal cancer cell lines. | BMC Complement Med Ther | 2023 | 37464362 | PubTator, text mining | PubMed |
| Combination of an Oxindole Derivative with (-)-β-Elemene Alters Cell Death Pathways in FLT3/ITD+ Acute Myeloid Leukemia Cells. | Molecules | 2023 | 37446914 | PubTator, text mining | PubMed |
| GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer. | Int J Mol Sci | 2023 | 37446056 | PubTator, text mining | PubMed |
| Current Insights into Cellular Determinants of Peritoneal Fibrosis in Peritoneal Dialysis: A Narrative Review. | J Clin Med | 2023 | 37445436 | PubTator, text mining | PubMed |
| Dysregulation of a lncRNA within the TNFRSF10A locus activates cell death pathways. | Cell Death Discov | 2023 | 37443108 | PubTator, text mining | PubMed |
| Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34+ progenitor cell-derived NK cells. | iScience | 2023 | 37426355 | PubTator, text mining | PubMed |
| The autophagic protein FYCO1 controls TNFRSF10/TRAIL receptor induced apoptosis and is inactivated by CASP8 (caspase 8). | Autophagy | 2023 | 37418591 | PubTator, text mining | PubMed |
| Preoperative immunological plasma markers TRAIL, CSF1 and TIE2 predict survival after resection for biliary tract cancer. | Front Oncol | 2023 | 37404757 | PubTator, text mining | PubMed |
| Identification of immunity-related lncRNAs and construction of a ceRNA network of potential prognostic biomarkers in acute myeloid leukemia. | Front Genet | 2023 | 37388937 | PubTator, text mining | PubMed |
| A systems biology approach uncovers novel disease mechanisms in age-related macular degeneration. | Cell Genom | 2023 | 37388919 | PubTator, text mining | PubMed |
| The Roles of Zinc Finger Proteins in Colorectal Cancer. | Int J Mol Sci | 2023 | 37373394 | PubTator, text mining | PubMed |
| Recent Advances in CAR-Based Solid Tumor Immunotherapy. | Cells | 2023 | 37371075 | PubTator, text mining | PubMed |
| Effect of Zebularine on Apoptotic Pathways in Hepatocellular Carcinoma Cell Lines. | Int J Prev Med | 2023 | 37351028 | PubTator, text mining | PubMed |
| The Role of TRAIL in Apoptosis and Immunosurveillance in Cancer. | Cancers (Basel) | 2023 | 37345089 | PubTator, text mining | PubMed |
| Long non-coding RNAs regulate Aedes aegypti vector competence for Zika virus and reproduction. | PLoS Pathog | 2023 | 37319296 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8793/papers?page=4